FDA Adverse Event Malfunction Summary report: N

TRUERESULT

MDR report key: 6689441 · Received July 6, 2017

Report

Report Number
1000113657-2017-01236
Event Type
Malfunction
Date Received
July 6, 2017
Date of Event
January 25, 2016
Report Date
July 6, 2017
Manufacturer
TRIVIDIA HEALTH, INC.
Product Code
NBW
PMA / PMN Number
K080641
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INTERNAL REPORT # (B)(4). RETURNED METER AND RETURNED TEST STRIPS EVALUATED WITH NO DEFECTS FOUND. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION: USER HAD AN INACCURATE REFERENCE. BASED ON REVIEW WITH FDA ON 06/21/2017, WE VERIFIED THE AGENCY'S INTERPRETATION OF THE ACT AND SUBMIT THIS MEDWATCH REPORT BASED ON THE NATURE OF THE COMPLAINT FOR THIS RECALLED LOT. RECALL #FDA-ASSIGNED RECALL EVENT ID (B)(4).

Description of Event or Problem · 1

CONSUMER REPORTED COMPLAINT FOR LOW RESULTS. CUSTOMER REPORTED NO SYMPTOMS, AND DOES NOT NEED MEDICAL ATTENTION. STRIP EXPIRATION DATE IS 06/30/2018 AND STRIP OPEN DATE IS (B)(6) 2016. STRIP STORAGE IS CORRECT. BACK TO BACK BLOOD TEST PERFORMED NON-FASTING AND RESULTS ARE 200MG/DL AND 190MG/DL REVIEWED METER MEMORY (DATE / TIME NOT SET) THE 176MG/DL (B)(6) 2016 08:47:00 AM FASTING:YES, THE 120MG/DL (B)(6) 2016 07:00:00 PM FASTING:YES, THE 171MG/DL (B)(6) 2015 10:43:00 PM FASTING:YES, THE 188MG/DL (B)(6) 2016 08:51:00 AM FASTING:YES, THE 143MG/DL (B)(6) 2015 06:22:00 AM FASTING:YES. CUSTOMER CALLING CONCERNED HIS METER IS READING LOWER THAN HIS DOCTOR'S METER. CUSTOMER PERFORMED A BACK TO BACK BLOOD TEST ON (B)(6) 2016 AT 09:05 AM FASTING AND RECEIVED A RESULT OF 192 MG/DL AND AT THE DOCTOR'S OFFICE USING THE FACILITY METER CUSTOMER RECEIVED A RESULT OF 255 MG /DL . CUSTOMER STATES HIS NORMAL GLUCOSE RANGE IS 132-165 MG /DL FASTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
471825 TRUERESULT BLOOD GLUCOSE SYSTEM NBW TRIVIDIA HEALTH, INC. TRUERESULT PS2383

Patients

Seq Age Sex Outcome Treatment
1 0 YR